---
$id: https://graph.org.ai/products/commodity/51131640
$type: Product
source: UNSPSC
code: "51131640"
title: "Gabexate"
class: "51131600"
classTitle: "Anticoagulants"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Gabexate

**UNSPSC Code**: 51131640
**Class**: [Anticoagulants](Anticoagulants.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a protease inhibitor and anticoagulant agent with the molecular formula C16H23N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4V7M9137X9, chemically known as benzoic acid, 4-((6-((aminoiminomethyl)amino)-1-oxohexyl)oxy)-, ethyl ester but generally known as gabexate, which bears US NIH Compound Identifier 3447. European Medicines Agency schedules Gabexate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07858MIG. The term GABEXATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). GABEXATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule gabexate under HS 29252900 and SITC 51482. As of Q4 2014, GABEXATE remains the US FDA Preferred Term for this commodity. Gabexate bears US NLM identifiers UMLS ID C0085231 and NCI Concept Code C76960. SMILES: O(C(=O)CCCCC/N=C(/N)N)C1CCC(CC1)C(=O)OCC.

